FEGHALIDENTAL
The computed 12-month bankruptcy probability of FEGHALIDENTAL is 0.3% (very low). The 2024 annual accounts show equity of €109k and a net result of €41k. Equity is growing by ~42.4% per year across the filed fiscal years. Its solvency ranks better than 86% of 6559 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €109k |
| Net result | €41k |
| Better than sector | 86% |
| Active | 3 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 90.2% | 66.7% | |
| Net result | €41k | €46k | |
| Equity | €109k | €79k | |
| Gross operating margin | €53k | €78k | |
| Total assets | €121k | €154k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €53k |
| Net profit | €41k |
| Cash flow | €42k |
| Staff costs | - |
| Income taxes | €11k |
| Dividends | - |
| Total assets | €121k |
| Equity | €109k |
| Debt | €12k |
| of which ≤ 1y | €12k |
| of which > 1y | - |
| Working capital | €106k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 9.95 |
| Quick ratio | 9.95 |
| Working capital ratio | 87.5% |
| Solvency | 90.2% |
| Debt / equity | 0.11 |
| Long-term debt ratio | - |
| Interest coverage | 1179.69 |
| Gross margin | - |
| Net margin | - |
| ROA | 33.8% |
| ROE | 37.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €121k |
| Fixed assets | 21/28 | €3k |
| Tangible fixed assets | 22/27 | €3k |
| Current assets | 29/58 | €117k |
| Amounts receivable within one year | 40/41 | €4k |
| Cash & bank | 54/58 | €113k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €121k |
| Equity | 10/15 | €109k |
| Contributions / capital | 10/11 | €4k |
| Reserves | 13 | €105k |
| Amounts payable | 17/49 | €12k |
| Amounts payable within one year | 42/48 | €12k |
| Trade debts payable within one year | 44 | €34 |
| Income statement | ||
| Gross operating margin | 9900 | €53k |
| Operating result | 9901 | €52k |
| Financial charges | 65 | €45 |
| Result before taxes | 9903 | €52k |
| Income taxes | 67/77 | €11k |
| Net result for the period | 9904 | €41k |
| Result to be appropriated | 9905 | €41k |
| NACE primary | Human health(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 29-11-2022 |
| Status | Active |
| Postal code | 1090 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21445C0281/00P005 | Brussels | 4,911 m² | 1 · 2,859 m² | 21.3 m · 5 fl. |
| 21010B0158/00K002 | Brussels | 1,351 m² | 1 · 496 m² | 24.4 m · 8 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
27-10-2025 Registered office moved from IXELLES to JETTE
- Boulevard du Triomphe 151, 1050 IXELLES → Rue Duysburgh 60, 1090 JETTE
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "JETTE",
"region": "Brussels Gewest",
"street": "Rue Duysburgh",
"country": "BE",
"postcode": "1090",
"box_number": "6",
"street_number": "60"
},
"old_address": {
"city": "IXELLES",
"region": "Brussels Gewest",
"street": "Boulevard du Triomphe",
"country": "BE",
"postcode": "1050",
"box_number": "B255",
"street_number": "151"
},
"effective_date": "2025-09-16",
"evidence_quote": "Le transfert du si\u00E8ge social de la soci\u00E9t\u00E9 \u00E0 l\u0027adresse suivante et ce, \u00E0 partir du 16 septembre 2025: Rue Duysburgh 60 bte 6 \u00E0 1090 JETTE."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0794.177.206",
"name_full": "FEGHALIDENTAL",
"legal_form": "SRL"
}
}01-12-2022 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "1050 Ixelles, Boulevard du Triomphe 151 bte B255",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "EL FEGHALI Christopher",
"niss": null,
"address": null
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 1855,
"holder_person_name": "EL FEGHALI Christopher",
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 1855,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 1855,
"subject_company": {
"kbo": "0794.177.206",
"name_full": "FEGHALIDENTAL",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2022-11-29",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | FEGHALIDENTAL |